FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4214883654> ?p ?o ?g. }

• W4214883654 endingPage "566" @default.
• W4214883654 startingPage "551" @default.
• W4214883654 abstract "Postoperative pulmonary complications are common. Aging and respiratory disease provoke airway hyperresponsiveness, high-risk surgery induces diaphragmatic dysfunction, and general anesthesia contributes to atelectasis and peripheral airway injury. This study therefore tested the hypothesis that inhalation of penehyclidine, a long-acting muscarinic antagonist, reduces the incidence of pulmonary complications in high-risk patients over the initial 30 postoperative days.This single-center double-blind trial enrolled 864 patients age over 50 yr who were scheduled for major upper-abdominal or noncardiac thoracic surgery lasting 2 h or more and who had an Assess Respiratory Risk in Surgical Patients in Catalonia score of 45 or higher. The patients were randomly assigned to placebo or prophylactic penehyclidine inhalation from the night before surgery through postoperative day 2 at 12-h intervals. The primary outcome was the incidence of a composite of pulmonary complications within 30 postoperative days, including respiratory infection, respiratory failure, pleural effusion, atelectasis, pneumothorax, bronchospasm, and aspiration pneumonitis.A total of 826 patients (mean age, 64 yr; 63% male) were included in the intention-to-treat analysis. A composite of pulmonary complications was less common in patients assigned to penehyclidine (18.9% [79 of 417]) than those receiving the placebo (26.4% [108 of 409]; relative risk, 0.72; 95% CI, 0.56 to 0.93; P = 0.010; number needed to treat, 13). Bronchospasm was less common in penehyclidine than placebo patients: 1.4% (6 of 417) versus 4.4% (18 of 409; relative risk, 0.327; 95% CI, 0.131 to 0.82; P = 0.011). None of the other individual pulmonary complications differed significantly. Peak airway pressures greater than 40 cm H2O were also less common in patients given penehyclidine: 1.9% (8 of 432) versus 4.9% (21 of 432; relative risk, 0.381; 95% CI, 0.171 to 0.85; P = 0.014). The incidence of other adverse events, including dry mouth and delirium, that were potentially related to penehyclidine inhalation did not differ between the groups.In high-risk patients having major upper-abdominal or noncardiac thoracic surgery, prophylactic penehyclidine inhalation reduced the incidence of pulmonary complications without provoking complications." @default.
• W4214883654 created "2022-03-05" @default.
• W4214883654 creator A5001731363 @default.
• W4214883654 creator A5026680359 @default.
• W4214883654 creator A5036581174 @default.
• W4214883654 creator A5039086422 @default.
• W4214883654 creator A5042996287 @default.
• W4214883654 creator A5043347603 @default.
• W4214883654 creator A5050359552 @default.
• W4214883654 creator A5053345410 @default.
• W4214883654 creator A5069564356 @default.
• W4214883654 creator A5083455588 @default.
• W4214883654 creator A5087473493 @default.
• W4214883654 date "2022-02-28" @default.
• W4214883654 modified "2023-10-06" @default.
• W4214883654 title "Prophylactic Penehyclidine Inhalation for Prevention of Postoperative Pulmonary Complications in High-risk Patients: A Double-blind Randomized Trial" @default.
• W4214883654 cites W1687620054 @default.
• W4214883654 cites W1722707720 @default.
• W4214883654 cites W1844932135 @default.
• W4214883654 cites W1915939554 @default.
• W4214883654 cites W1973295271 @default.
• W4214883654 cites W1974495703 @default.
• W4214883654 cites W2001894382 @default.
• W4214883654 cites W2003583976 @default.
• W4214883654 cites W2005839540 @default.
• W4214883654 cites W2017032730 @default.
• W4214883654 cites W2025209079 @default.
• W4214883654 cites W2026450237 @default.
• W4214883654 cites W2030218597 @default.
• W4214883654 cites W2032171019 @default.
• W4214883654 cites W2042927727 @default.
• W4214883654 cites W2066900584 @default.
• W4214883654 cites W2099557520 @default.
• W4214883654 cites W2110723493 @default.
• W4214883654 cites W2129582100 @default.
• W4214883654 cites W2133957981 @default.
• W4214883654 cites W2157100110 @default.
• W4214883654 cites W2178422374 @default.
• W4214883654 cites W2282968034 @default.
• W4214883654 cites W2295407912 @default.
• W4214883654 cites W2316759117 @default.
• W4214883654 cites W2323383853 @default.
• W4214883654 cites W2337700441 @default.
• W4214883654 cites W2525291310 @default.
• W4214883654 cites W2528916269 @default.
• W4214883654 cites W2583265473 @default.
• W4214883654 cites W2593118437 @default.
• W4214883654 cites W2742454714 @default.
• W4214883654 cites W2748645463 @default.
• W4214883654 cites W2769096020 @default.
• W4214883654 cites W2774093552 @default.
• W4214883654 cites W2921878836 @default.
• W4214883654 cites W2925052722 @default.
• W4214883654 cites W2952861445 @default.
• W4214883654 cites W3003483921 @default.
• W4214883654 cites W3015147275 @default.
• W4214883654 cites W3092304780 @default.
• W4214883654 cites W3205425601 @default.
• W4214883654 cites W2028086381 @default.
• W4214883654 doi "https://doi.org/10.1097/aln.0000000000004159" @default.
• W4214883654 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35226725" @default.
• W4214883654 hasPublicationYear "2022" @default.
• W4214883654 type Work @default.
• W4214883654 citedByCount "7" @default.
• W4214883654 countsByYear W42148836542022 @default.
• W4214883654 countsByYear W42148836542023 @default.
• W4214883654 crossrefType "journal-article" @default.
• W4214883654 hasAuthorship W4214883654A5001731363 @default.
• W4214883654 hasAuthorship W4214883654A5026680359 @default.
• W4214883654 hasAuthorship W4214883654A5036581174 @default.
• W4214883654 hasAuthorship W4214883654A5039086422 @default.
• W4214883654 hasAuthorship W4214883654A5042996287 @default.
• W4214883654 hasAuthorship W4214883654A5043347603 @default.
• W4214883654 hasAuthorship W4214883654A5050359552 @default.
• W4214883654 hasAuthorship W4214883654A5053345410 @default.
• W4214883654 hasAuthorship W4214883654A5069564356 @default.
• W4214883654 hasAuthorship W4214883654A5083455588 @default.
• W4214883654 hasAuthorship W4214883654A5087473493 @default.
• W4214883654 hasBestOaLocation W42148836541 @default.
• W4214883654 hasConcept C126322002 @default.
• W4214883654 hasConcept C141071460 @default.
• W4214883654 hasConcept C142724271 @default.
• W4214883654 hasConcept C204787440 @default.
• W4214883654 hasConcept C27081682 @default.
• W4214883654 hasConcept C2776042228 @default.
• W4214883654 hasConcept C2776178081 @default.
• W4214883654 hasConcept C2777714996 @default.
• W4214883654 hasConcept C2778088044 @default.
• W4214883654 hasConcept C2778329176 @default.
• W4214883654 hasConcept C2781101014 @default.
• W4214883654 hasConcept C42219234 @default.
• W4214883654 hasConcept C44249647 @default.
• W4214883654 hasConcept C71924100 @default.
• W4214883654 hasConcept C75603125 @default.
• W4214883654 hasConcept C82789193 @default.
• W4214883654 hasConceptScore W4214883654C126322002 @default.
• W4214883654 hasConceptScore W4214883654C141071460 @default.
• W4214883654 hasConceptScore W4214883654C142724271 @default.

• next